Sequenom, Inc. Announces Participation At The 26th Annual Roth Conference
SAN DIEGO, March 3, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the 26th Annual Roth Conference at the Ritz Carlton in Dana Point, CA on March 9-12, 2014.
William Welch, President and Chief Operating Officer, and Carolyn D. Beaver, Vice President and Chief Accounting Officer, will present on Tuesday, March 11, beginning at 12:00 p.m. PT to provide an overview of and update on the Company. The presentation is expected to last approximately 25 minutes and will be webcast live through the "Investors" section of the Sequenom Web site at www.sequenom.com. An audio replay will be available for 30 days following the initial broadcast.
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genomic and genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostic markets. Website: www.sequenom.com
SOURCE Sequenom, Inc.